Literature DB >> 16628235

Linear pattern of West Nile virus-associated chorioretinitis is related to retinal nerve fibres organization.

M Khairallah1, S Ben Yahia, S Attia, S Zaouali, A Ladjimi, R Messaoud.   

Abstract

PURPOSE: To clarify the reason for the linear pattern of West Nile virus (WNV)-associated chorioretinitis.
METHODS: The study included 12 patients (24 eyes) with WNV-associated chorioretinitis. All the patients underwent a complete ophthalmic evaluation, including dilated fundus examination, fundus photography, fluorescein angiography, and indocyanine green angiography. Characteristics of linear streaks, particularly their relationship to the course of retinal and choroidal vessels, and pattern of retinal nerve fibres, were analysed.
RESULTS: All patients had bilateral multifocal chorioretinitis with linear clustering of chorioretinal lesions associated with a variable number of scattered lesions. Linear streaks, variable in number and length, originated from the optic disc or its vicinity in most cases. Their course in all cases appeared to closely follow the course of retinal nerve fibres, rather than that of retinal or choroidal vessels.
CONCLUSIONS: Results of our study show that the linear pattern of WNV-associated chorioretinitis is related to retinal nerve fibres organization, suggesting a contiguous spread of WNV virus from central nerve system via the optic nerve fibres to the outer retina, retinal pigment epithelium, and choroid.

Entities:  

Mesh:

Year:  2006        PMID: 16628235     DOI: 10.1038/sj.eye.6702355

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  16 in total

Review 1.  Novel infectious agents causing uveitis.

Authors:  Moncef Khairallah; Soon Phaik Chee; Sivakumar R Rathinam; Sonia Attia; Venu Nadella
Journal:  Int Ophthalmol       Date:  2009-08-27       Impact factor: 2.031

Review 2.  Viral posterior uveitis.

Authors:  Joanne H Lee; Aniruddha Agarwal; Padmamalini Mahendradas; Cecilia S Lee; Vishali Gupta; Carlos E Pavesio; Rupesh Agrawal
Journal:  Surv Ophthalmol       Date:  2016-12-22       Impact factor: 6.048

Review 3.  Emerging causes of viral-associated uveitis.

Authors:  Daniel B Connors; Jessica G Shantha; Steven Yeh
Journal:  Int Ophthalmol Clin       Date:  2015

Review 4.  A new era of uveitis: impact of polymerase chain reaction in intraocular inflammatory diseases.

Authors:  Manabu Mochizuki; Sunao Sugita; Koju Kamoi; Hiroshi Takase
Journal:  Jpn J Ophthalmol       Date:  2016-10-27       Impact factor: 2.447

5.  Emergent infectious uveitis.

Authors:  Moncef Khairallah; Bechir Jelliti; Salah Jenzeri
Journal:  Middle East Afr J Ophthalmol       Date:  2009-10

6.  West Nile Virus Infection in Human and Mouse Cornea Tissue.

Authors:  Bradley J Blitvich; Tian Wang; Vandana Saxena; Shemin Zeng; Karen M Harmon; Matthew D Raymond; Kenneth M Goins; Cynthia R Reed; Robert F Mullins; Mark A Greiner
Journal:  Am J Trop Med Hyg       Date:  2016-09-26       Impact factor: 2.345

Review 7.  [Tropical ophthalmology : Intraocular inflammation caused by "new" infectious pathogens and travel-related infections].

Authors:  U Pleyer; V Klauß; H Wilking; M M Nentwich
Journal:  Ophthalmologe       Date:  2016-01       Impact factor: 1.059

8.  Measuring the burden of arboviral diseases: the spectrum of morbidity and mortality from four prevalent infections.

Authors:  A Desirée Labeaud; Fatima Bashir; Charles H King
Journal:  Popul Health Metr       Date:  2011-01-10

9.  Microarray analysis of gene expression in West Nile virus-infected human retinal pigment epithelium.

Authors:  Luis Munoz-Erazo; Ricardo Natoli; Jan Marie Provis; Michelle Catherine Madigan; Nicholas Jonathan Cole King
Journal:  Mol Vis       Date:  2012-03-27       Impact factor: 2.367

Review 10.  Antiviral macrophage responses in flavivirus encephalitis.

Authors:  Thomas Myles Ashhurst; Caryn van Vreden; Luis Munoz-Erazo; Paula Niewold; Kanami Watabe; Rachael L Terry; Celine Deffrasnes; Daniel R Getts; Nicholas Jonathan Cole King
Journal:  Indian J Med Res       Date:  2013-11       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.